Results 191 to 200 of about 3,851,257 (282)

A Connected Building Landscape dataset for Instance Segmentation. [PDF]

Sci Data
Zheng Z, Chen Z, Sun S, Qian X, Guo W.
europepmc   +1 more source

Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors

British Journal of Clinical Pharmacology, EarlyView.
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem, Mohannad N. AbuHaweeleh, Humam Emad Rajha, Mhd Osama Rahhal, Ahmad Hamdan, Lina Naseralallah   +5 more
wiley   +1 more source

Design of MOSAAIC (Multi-Ethnic Observational Study in American Asian and Pacific Islander Communities). [PDF]

JACC Asia
Ahn J, Ahsan H, Anderson GL, Aschebrook-Kilfoy B, Beery D, Carrick W, Celedón JC, Chan KCG, Chen Y, Ðoàn LN, Fang CY, Floyd JS, Hayes RB, Henderson V, Hong Y, Hsing AW, Hsu L, Hu FB, Jin JL, John EM, Kanaya AM, Kaplan RC, Kibriya MG, Kim K, Kushida C, Lampe JW, Li S, Lu Y, Ma GX, Mau MKLM, Maunakea AK, Mendoza JA, Neuhouser ML, Newman JD, Odden MC, Palaniappan L, Park SL, Randal F, Rhew IC, Santos S, Soliman EZ, Thyagarajan B, Hsin-Chun Tsai J, VoPham T, Wang P, Wion E, Yan Y, Yi SS, Zhu L, MOSAAIC Investigators.   +49 more
europepmc   +1 more source

HLA‐B*15:21 carrier status is a susceptibility factor of carbamazepine‐induced nonimmediate cutaneous adverse reactions in HLA‐B*15:02‐negative patients: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
After HLA‐B*15:02 screening, the residual risk of carbamazepine‐induced nonimmediate cutaneous adverse reactions is 0.059. Among these HLA‐B*15:02‐negative cases, HLA‐B*15:11 and HLA‐B*15:21 carrier status significantly increases the risk of carbamazepine‐induced nonimmediate cADR.
Warit Ruanglertboon, Chutima Seree‐aphinan, Antida Sangiemchoey, Khwanchanok Kaewpiboon, Taweesak Maneerot, Oradawan Plong‐on, Pornsiri Sangmanee, Punthipa Nichanon, Jariya Khayman, Jiraphan Manee, Areerat Hnoonual, Kanoot Jaruthamsophon   +11 more
wiley   +1 more source

A Validated Assessment Scale for the Auriculocephalic Angle in Asians. [PDF]

Aesthetic Plast Surg
Hong WJ, Wang SW, Zhao HY, Zou MY, Zhang SY, Wang HB, Ling Y, Cai W, Huang JM, Zeng D, Day D, Fritz K, Green J, Hernandez C, Kerscher M, Rzany B, Pooth R, Ghanem A, Luo SK.   +18 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Euro-Asian hybrids of Echinococcus multilocularis from red foxes in northern and northeastern Poland result from secondary contact between long-isolated populations. [PDF]

Sci Rep
Gładysz P, Bielińska-Wąż D, Wąż P, Samorek-Pieróg M, Karamon J, Lass A.   +5 more
europepmc   +1 more source

Rethinking the “Middle East” as an Object of Study (AFMA Paper, The 10th Asian Federation of Middle East Studies Associations (AFMA) Conference De/Re-constructing Middle East Studies from Asian Perspectives)

Annals of Japan Association for Middle East Studies, 2015
openaire   +1 more source

Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications

British Journal of Clinical Pharmacology, EarlyView.
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba, Mishael Ssesanga, Munir Pirmohamed   +2 more
wiley   +1 more source

Cross-cultural analysis of eye-movement patterns in visual scene perception: a comparison of seven cultural samples. [PDF]

Sci Rep
Čeněk J, Halámková D, Caha J, Lacko D, Kalenská P, Stachoň Z, Tsai JL, Ahenkan A, Dresler T, Lüdtke J, Dostálová N, Šašinková A, Ugwitz P, Šašinka Č.   +13 more
europepmc   +1 more source